feed,title,long_url,short_url
Benzinga,Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study,https://benzinga.com/general/biotech/21/10/23277156/bristol-myers-tyk2-inhibitor-disappoints-in-mid-stage-ulcerative-colitis-study,https://j.mp/3uRtWCt
Benzinga,How Does Global Supply Chain Emissions Tracking Level Playing Field?,https://benzinga.com/government/21/10/23279415/how-does-global-supply-chain-emissions-tracking-level-playing-field,https://j.mp/3DjS6bL
Benzinga,Why Snap Shares Are Rising,https://benzinga.com/news/21/10/23281613/why-snap-shares-are-rising,https://j.mp/3iCdP6L
Benzinga,BioSig Inks Manufacturing Deal with Plexus Corp,https://benzinga.com/general/biotech/21/10/23281567/biosig-inks-manufacturing-deal-with-plexus-corp,https://j.mp/2WVBPug
Benzinga,Supply Chain Braces for Peak Retail Returns: How Companies Should Prepare,https://benzinga.com/news/21/10/23280599/supply-chain-braces-for-peak-retail-returns-how-companies-should-prepare,https://j.mp/3uSb9Xz
Benzinga,Why Are Marvell Shares Trading Higher Today?,https://benzinga.com/analyst-ratings/analyst-color/21/10/23280539/why-are-marvell-shares-trading-higher-today,https://j.mp/3uQAH7E
